Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00795743 · ClinicalTrials.gov registry record
Coagulation Changes in Trauma Patients
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 40
- Enrollment target
NCT00795743 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 40 participants.
The verdict
NCT00795743 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
Hypothesis to be tested: placement of a central venous catheter will induce a systemic hypercoagulable state. To determine this, the investigators will measure thromboelastography (TEG), PT(prothrombin time), PTT (partial thromboplastin time), Prothrombin Fragment 1.2, Factor VIII, and VonWillebrand's Factor. In addition, duplex ultrasound will be performed to correlate the laboratory coagulation values with functional changes (i.e. deep venous thrombosis).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-02 |
| Est. Completion | 2012-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00795743
The ClinicalTrials.gov registry entry for NCT00795743 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00795743 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00795743 about?
NCT00795743 is a clinical study titled "Coagulation Changes in Trauma Patients". Hypothesis to be tested: placement of a central venous catheter will induce a systemic hypercoagulable state. To determine this, the investigators will measure thromboelastography (TEG), PT(prothrombin time), PTT (partial thromboplastin time), Prothrombin Fragment 1.2, Factor VIII, and VonWillebrand...
What is the current status of trial NCT00795743?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2008-02. Estimated completion is 2012-06.
Who is sponsoring clinical trial NCT00795743?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.